This poster reports the first descriptive analysis of the global WAYFIND-R cohort
Blay J-Y., et al. WAYFIND-R: A global, real-world database of patients (pts) with a solid tumour profiled with next-generation sequencing (NGS).
ESMO 2023, poster # 206P.
This poster describes socio-demographic and socio-economic characteristics of the global WAYFIND-R population
Hackshaw A., et al., WAYFIND-R: A Global, Real-World Precision Oncology Registry – Socioeconomic Features.
ISPOR Europe 2023.
WAYFIND-R Platform Launch
Launch of the WAYFIND-R Data Sharing and Collaboration Platform!
The WAYFIND-R team is excited to announce the launch of the WAYFIND-R Data Sharing and Collaboration Platform. This platform provides the medical and scientific community with access to high-quality data and enables research collaborations to help advance precision oncology.
This poster highlights the key features of the WAYFIND-R RWD Registry for Solid Tumors with NGS Testing
Le Tourneau, C., et al. WAYFIND-R: Delivering a high-quality real-world data (RWD) global registry of patients diagnosed with a solid tumor and profiled with next-generation sequencing (NGS),
AACR Annual Meeting 2022, poster #4094.
This poster conceptualizes the core variables within the WAYFIND-R registry and how it supports future research with a harmonized approach
Dienstmann, R., et al Conceptualization of core clinico-molecular variables for registries enrolling patients diagnosed with a solid tumor and profiled with next-generation sequencing (NGS),
AACR Annual Meeting 2022, poster #5246.
This journal in the JCO Precision Oncology discusses the approach to solving the complex clinicogenomic data landscape in precision oncology and the learning from WAYFIND-R
Le Tourneau, C., et al. An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry.
JCO Precis Oncol. 2022;6:e2200019.
If you are interested in joining WAYFIND-R, please contact us by filling out the form below to learn more about eligibility criteria and the next steps.